These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34715874)

  • 1. Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma.
    Leite TC; Watters RJ; Weiss KR; Intini G
    J Transl Med; 2021 Oct; 19(1):450. PubMed ID: 34715874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein.
    Zhang H; Guo X; Feng X; Wang T; Hu Z; Que X; Tian Q; Zhu T; Guo G; Huang W; Li X
    Oncotarget; 2017 Jan; 8(2):2342-2355. PubMed ID: 27911265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
    Du JY; Wang LF; Wang Q; Yu LD
    Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B.
    Mizushima E; Tsukahara T; Emori M; Murata K; Akamatsu A; Shibayama Y; Hamada S; Watanabe Y; Kaya M; Hirohashi Y; Kanaseki T; Nakatsugawa M; Kubo T; Yamashita T; Sato N; Torigoe T
    Cancer Sci; 2020 Jan; 111(1):36-46. PubMed ID: 31705593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑186 functions as a tumor suppressor in osteosarcoma cells by suppressing the malignant phenotype and aerobic glycolysis.
    Xiao Q; Wei Z; Li Y; Zhou X; Chen J; Wang T; Shao G; Zhang M; Zhang Z
    Oncol Rep; 2018 Jun; 39(6):2703-2710. PubMed ID: 29693191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of glycolysis in osteosarcoma.
    Feng Z; Ou Y; Hao L
    Front Pharmacol; 2022; 13():950886. PubMed ID: 36059961
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Jovičić MŠ; Pušić M; Antunović M; Ledinski M; Librenjak L; Kolundžić R; Ribičić T; Trkulja V; Urlić I
    Acta Pharm; 2022 Dec; 72(4):599-613. PubMed ID: 36651364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK.
    Hu XK; Rao SS; Tan YJ; Yin H; Luo MJ; Wang ZX; Zhou JH; Hong CG; Luo ZW; Du W; Wu B; Yan ZQ; He ZH; Liu ZZ; Cao J; Wang Y; Situ WY; Liu HM; Huang J; Wang YY; Xia K; Qian YX; Zhang Y; Yue T; Liu YW; Zhang HQ; Tang SY; Chen CY; Xie H
    Theranostics; 2020; 10(17):7710-7729. PubMed ID: 32685015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
    Sottnik JL; Lori JC; Rose BJ; Thamm DH
    Clin Exp Metastasis; 2011 Dec; 28(8):865-75. PubMed ID: 21842413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
    Wan J; Liu Y; Long F; Tian J; Zhang C
    Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma.
    Wang B; Zhou Y; Zhang P; Li J; Lu X
    Am J Chin Med; 2023; 51(5):1293-1308. PubMed ID: 37367817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.
    Palorini R; Votta G; Balestrieri C; Monestiroli A; Olivieri S; Vento R; Chiaradonna F
    J Cell Biochem; 2014 Feb; 115(2):368-79. PubMed ID: 24030970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
    Wang W; Wang B
    BMC Cancer; 2022 May; 22(1):562. PubMed ID: 35590288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications.
    Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA
    Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
    Zheng XM; Xu CW; Wang F
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma.
    Li Z; Geng M; Ye X; Ji Y; Li Y; Zhang X; Xu W
    Int J Biol Sci; 2022; 18(1):30-42. PubMed ID: 34975316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis.
    Weng Y; Duan W; Yu X; Wu F; Yang D; Jiang Y; Wu J; Wang M; Wang X; Shen Y; Zhang Y; Xu H
    Cancer Sci; 2023 Jun; 114(6):2345-2359. PubMed ID: 36880587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma.
    Ren X; Su C
    Mol Med Rep; 2020 Sep; 22(3):2183-2190. PubMed ID: 32705189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.